OCT 7·SEC EDGARLow
Hawkins Matthew J. sold $2.2M of WAY
Hawkins Matthew J. (Chief Executive Officer) sold 82,500 shares of Waystar Holding Corp. (WAY) at $26.23 ($2.16M total) on 2026-10-06 under a Rule 10b5-1 trading plan.
StockNASDAQ · US · USDHealthcare · Health Information Services
$WAY
Waystar Holding Corp.
Price · $WAYvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $WAY in the last 7 days.
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $2.2M 1 txs
Hawkins Matthew J.1× · $2.2M
10b5-1 share of filings100%
Top stories · $WAYMore →
SEP 17·theglobeandmail.com
Analysts Offer Insights on NA Companies: Harmonic (HLIT), Waystar Holding Corp. (WAY) and Jack Henry & Associates (JKHY)
Analysts reiterated Buy ratings on Harmonic (HLIT) with a $20 target, Waystar (WAY) with a $33 target, and Jack Henry (JKHY) with a $178 target. Consensus targets are $17.50, $33.38, and $189.54 respectively. Analysts' track records and sector focuses were noted.
SEP 15·cnbc.com
Stocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more
Skyworks Solutions (SWKS) and Qorvo (QRVO) rose 10% and 7% respectively, recovering from prior sell-offs. Axon (AXON) fell 9% after a $1B convertible note sale. Revvity (RVTY) jumped 7% to a 52-week high, citing strong backlog. Dave & Buster's (PLAY) dropped 17% after missing Q2 revenue and EBITDA estimates. Enova (ENVA) tumbled 25% after withdrawing a regulatory application. Sysco (SYY) slid 3% on a 12.3M share offering. Alignment Healthcare (ALHC) fell 18% due to business headwinds. Waystar (W
WAY sentiment & insider activity
Recent WAY coverage spans mergers & acquisitions, insider activity and market movers.
In the last 30 days, WAY insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($2.2M). The most active reporter was Hawkins Matthew J., Chief Executive Officer, with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
What's driving WAY
The insider sale may signal personal liquidity needs or lack of confidence, but the amount is modest relative to total holdings.
New target implies upside from current levels.
M&A speculation lifts the stock despite prior decline.
The sale exploration could lead to a takeover premium or private buyout, driving short-term upside.
Potential sale could trigger a valuation premium and M&A activity.
AlphAI scores every news story that mentions WAY with an AI model for sentiment and relevance, and aggregates insider trades from Waystar Holding Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $WAY
Score
Hawkins Matthew J. sold $2.2M of WAY
Hawkins Matthew J. (Chief Executive Officer) sold 82,500 shares of Waystar Holding Corp. (WAY) at $26.23 ($2.16M total) on 2026-10-06 under a Rule 10b5-1 trading plan.
1 min read
Analysts Offer Insights on NA Companies: Harmonic (HLIT), Waystar Holding Corp. (WAY) and Jack Henry & Associates (JKHY)
Analysts reiterated Buy ratings on Harmonic (HLIT) with a $20 target, Waystar (WAY) with a $33 target, and Jack Henry (JKHY) with a $178 target. Consensus targets are $17.50, $33.38, and $189.54 respectively. Analysts' track records and sector focuses were noted.
2 min read
Stocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more
Skyworks Solutions (SWKS) and Qorvo (QRVO) rose 10% and 7% respectively, recovering from prior sell-offs. Axon (AXON) fell 9% after a $1B convertible note sale. Revvity (RVTY) jumped 7% to a 52-week high, citing strong backlog. Dave & Buster's (PLAY) dropped 17% after missing Q2 revenue and EBITDA estimates. Enova (ENVA) tumbled 25% after withdrawing a regulatory application. Sysco (SYY) slid 3% on a 12.3M share offering. Alignment Healthcare (ALHC) fell 18% due to business headwinds. Waystar (W
2 min read
WAY Stock Surges On Reported Sale Buzz — RBC Flags This Tech Giant As The ‘Obvious First Name’
Waystar (WAY) shares rose 8% after Reuters reported the company is exploring a sale, with RBC naming Oracle (ORCL) as a potential buyer. Waystar hired Evercore to explore options, though no deal is guaranteed. RBC maintains an 'Outperform' rating with a $44 target, citing strong private-market valuations. Evercore also sees a sale as plausible given WAY's 24% decline this year.
2 min readMedical Software-Maker Reportedly Mulls A Sale; Shares Pop
Waystar Holdings (WAY) shares rose Tuesday, crossing its 200-day average, on reports the medical software company is considering strategic options, including a potential sale. This follows the company's recent Investor Day event, which outlined growth plans.
2 min readPremarket movers: Dave & Buster’s fall on Q2 miss; Waystar gains on potential sale
U.S. stock futures fell on Tuesday due to higher Treasury yields, oil prices, and AI concerns. Sysco dropped 1.3% after a $1B stock offering for its Jetro acquisition. Waystar rose 3.3% on potential sale reports. Bitcoin fell 2.9%, affecting crypto-related stocks. Dave & Buster’s fell 11.2% after missing Q2 earnings estimates.
3 min readExclusive-Healthcare software firm Waystar explores options including sale, sources say
Waystar, a healthcare software firm, is exploring strategic options, including a potential sale, according to seven sources. The company, which went public in 2024, has hired Evercore as an advisor. Waystar's market value has dropped to $4.8 billion after a 24% decline in its share price this year. The company's strategy aims to leverage higher tech valuations, but investor concerns about AI disruption have pressured its stock.
2 min readWaystar shares climb in premarket on potential sale reports
Waystar (WAY) shares rose 3.3% premarket to $25.73 on reports it is exploring strategic options, including a potential sale. EQT (EQTAB) holds 13% of shares, with Canada Pension Plan and BlackRock (BLK) also as major stakeholders. The company went public in 2024.
1 min readHawkins Matthew J. sold $2.1M of WAY
Hawkins Matthew J. (Chief Executive Officer) sold 82,500 shares of Waystar Holding Corp. (WAY) at $25.97 ($2.14M total) on 2026-09-02 under a Rule 10b5-1 trading plan.
2 min readWaystar Launches New Agentic Solutions Transforming AI Into Action Across the Revenue Cycle
Waystar (Nasdaq: WAY) launched new AI-driven agentic capabilities to autonomously execute revenue cycle workflows. Features include autonomous claim resolution, conversational analytics, and patient financial engagement. The company aims to reduce administrative work and improve financial outcomes for healthcare providers.
3 min read